Mycotoxin Binders Effect on Ovaries of Pregnant Mice Exposed to Zearalenone

Mycotoxin, a secondary metabolite produced by mushroom, has proven to cause various cytotoxic effects to animals. Zearalenone is one type of mycotoxin which is produced by Fusarium graminearum mushroom and has a cytotoxic effect to the reproduction system and cattle productivity by inducing apoptosi...

Full description

Saved in:
Bibliographic Details
Main Authors: Prastiya, Ragil Angga (Author), Samik, Abdul (Author), Saputro, Amung Logam (Author)
Format: EJournal Article
Published: Fakultas Kedokteran Hewan Universitas Gadjah Mada bekerjasama dengan PB PDHI, 2019-06-01.
Subjects:
Online Access:Get Fulltext
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02793 am a22002893u 4500
001 JSV_UGM_48522_25132
042 |a dc 
100 1 0 |a Prastiya, Ragil Angga  |e author 
100 1 0 |e contributor 
700 1 0 |a Samik, Abdul  |e author 
700 1 0 |a Saputro, Amung Logam  |e author 
245 0 0 |a Mycotoxin Binders Effect on Ovaries of Pregnant Mice Exposed to Zearalenone 
260 |b Fakultas Kedokteran Hewan Universitas Gadjah Mada bekerjasama dengan PB PDHI,   |c 2019-06-01. 
500 |a https://jurnal.ugm.ac.id/jsv/article/view/48522 
520 |a Mycotoxin, a secondary metabolite produced by mushroom, has proven to cause various cytotoxic effects to animals. Zearalenone is one type of mycotoxin which is produced by Fusarium graminearum mushroom and has a cytotoxic effect to the reproduction system and cattle productivity by inducing apoptosis in the animal's ovaries, uterus, and placenta. This research tested the potentials of mycotoxin binders in eliminating the effect of zearalenone which can be seen from the expression of caspase 3, the content of malondialdehyde (MDA), and the quantity of corpus luteum in the ovaries of pregnant mice (Mus musculus). Twenty mice were grouped into five different treatments, namely K+ (not exposed to zearalenone and mycotoxin binders), K- (0.1 mg/mouse/day of zearalenone dosage), P1 (0.1 mg/mouse/day of zearalenone dosage and 0.5 mg/mouse/day of mycotoxin binder dosage), P2 (0.1 mg/mouse/day of zearalenone dosage and 1 mg/mouse/day of mycotoxin binders), and P3 (0.1 mg/mouse/day of zearalenone and 2 mg/mouse/day of mycotoxin binders), with 10-days treatment time. The results showed that the potentials of mycotoxin binders could be found on the gradual decline in the expression of caspase 3 in P1, P2 and P3 compared to that in K- (negative control). The results also showed a significant difference in the content of malondialdehyde (MDA) in K- compared to that in K+, P1, P2, and P3. Meanwhile, the quantity of corpus luteum in K- was also starkly different to that in K+, P1, P2, and P3. It can then be concluded that mycotoxin binders are very effective in eliminating the exposure of zearalenone.  
540 |a Copyright (c) 2019 Jurnal Sain Veteriner 
540 |a http://creativecommons.org/licenses/by-sa/4.0 
546 |a eng 
690
690 |a Caspase 3; Korpus Luteum; Mycotoxin binders; Malondialdehyde (MDA); Zearalenon 
655 7 |a info:eu-repo/semantics/article  |2 local 
655 7 |a info:eu-repo/semantics/publishedVersion  |2 local 
655 7 |a Peer-reviewed Article  |2 local 
786 0 |n Jurnal Sain Veteriner; Vol 37, No 1 (2019): Juni; 127-132 
786 0 |n 2407-3733 
787 0 |n https://jurnal.ugm.ac.id/jsv/article/view/48522/25132 
856 4 1 |u https://jurnal.ugm.ac.id/jsv/article/view/48522/25132  |z Get Fulltext